Human history cannot be understood well without understanding the causes and consequences
of human disease. This fact has become amply apparent over the past few decades as
the impacts of infectious diseases have been studied in the context of war, colonization,
and competition [1], [2], [3], [4], [5]. It is much less widely appreciated that the
reverse is also true. Historical studies of infectious diseases may help guide modern
health sciences to recognize options for controlling diseases of the present and future.
Ecologic and evolutionary perspectives are enmeshed with the historical perspective
of infectious diseases, because infectious agents spread and evolve over times scales
that accord with historical events. They may influence historical events and may be
influenced by such events. The influence of historical events on the evolution of
pathogens largely has been neglected until the past quarter century. It has become
clear that activities that were undertaken for one purpose can have unforeseen effects
on the evolution of important characteristics of pathogens, such as virulence (which
is defined broadly here to mean the degree of harm imposed on the host). An understanding
of these evolutionary effects helps in understanding why some pathogens cause more
harm than others, the environmental circumstances that permit this harm, and, most
importantly for the future, the human activities that can ameliorate or prevent this
harm.
1
Evolutionary theory about virulence
For most of the 20th century, the prevailing dogma was that disease organisms eventually
should evolve toward benign coexistence with their hosts; harmful diseases were interpreted
as a transitory state of maladaptation [6], [7]. This belief has not been useful for
ameliorating the suffering caused by infectious diseases, because it suggests that
the occurrence of severe disease is bad luck and that not much can be done to control
this evolutionary process. This view arose more from assumptions about the harmony
of nature than from rigorous application of evolutionary principles. Specifically,
it failed to cast the problem in the context of natural selection. Rather than asking
whether harmful or mild variants would win out in competition with each other over
the short run, the focus was on what was stable over the long run. Natural selection
is powerless to favor long-term stability if the variants that win in the short term
destabilize the system. Natural selection may favor the evolution of extreme harmfulness
if the host exploitation that causes this harm enhances the competitive success of
the harmful variants over benign variants in the short run. If predator-like variants
of a pathogen population out-produce and out-transmit benign variants, benign coexistence
may be precluded. Instead of generating long-term stability, the evolutionary conflict
of interest between a predator-like pathogen and its host generates an evolutionary
arms race in which pathogen and host each evolve characteristics that give them a
leg up on the other, shifting the level of host exploitation closer to the optimum
for the pathogen or that of the host.
Before the last 2 decades of the 20th century, a few authors expressed reservations
about the traditional dogma [8], [9], [10], but they largely were ignored. Over the
past quarter century, however, the evolution of virulence has been broadly investigated
by a theoretical framework that is based on the principles of natural selection [11],
[12], [13], [14], [15]. This framework offers explanations for the broad range of
virulence found among host parasite relationships and offers possibilities for virulence
management (ie, the control of diseases by controlling the evolution of virulence)
[16]. The evolutionary framework also provides insight into the true scope of infectious
causation of chronic disease and a sense of which diseases can be prevented or cured
by developing disease-control strategies, such as vaccines and antibiotics.
2
Acute infectious diseases
For acute infectious diseases, theory about the evolution of virulence focuses on
the negative effects of virulence on transmission of pathogens between hosts. Much
of the variation in these negative effects of virulence depends on whether pathogens
can be transmitted from hosts that have become immobilized by the infections. Pathogens
that can be transmitted readily from immobile hosts should be molded by natural selection
to exploit hosts severely and to be highly virulent [5]. The reason is simple. Variants
that exploit severely gain the competitive advantages of this exploitation while incurring
little, if any, competitive cost from the illness that their exploitation generates,
because they still can be transmitted from hosts that have the severe, immobilizing
illness. Specific applications of this idea are presented.
2.1
Vector-borne transmission
Parasites transmitted by biting arthropods can be transmitted effectively from immobilized
hosts and therefore should evolve to a higher level of virulence than directly transmitted
parasites. A comparison of viral, bacterial, and protozoal agents of human diseases
showed that vector-borne pathogens are more lethal on a per-infection basis than are
directly transmitted pathogens [12]. The association between vector-borne transmission
and virulence explains why diseases such as malaria, yellow fever, dengue, sleeping
sickness, and visceral leishmaniasis are so severe, whereas most of the respiratory-tract
pathogens of humans are relatively benign.
A follow-up comparison of vector-borne pathogens indicates that this greater virulence
of vector-borne pathogens is related to adaptation to the conditions of vector-borne
transmission rather than to some spurious correlate of vector-borne transmission,
such as injection of a pathogen below the surface of the skin. This follow-up comparison
used historical data to assess the virulence of particular vector-borne pathogens
in humans in relation to the degree to which the pathogen had evolved in response
to vector-borne transmission between humans. Specifically, it compared the virulence
of vector-borne pathogens that had just been transmitted to humans with the virulence
of the same kind of vector-borne pathogen that had been cycling extensively in humans
and should be better adapted to vector-borne transmission between humans. As expected
from evolutionary theory, the pathogens that had been cycling in humans were more
severe in humans than those that recently had been introduced to humans from some
other vertebrate host [12]. The yellow fever virus, for example, was less deadly in
humans just after it entered the human population than it was in outbreaks that involved
extensive cycling of transmission between mosquitoes and humans.
Evolutionary management of the virulence of vector-borne diseases requires interventions
that elevate the immobilization of hosts more costly to the infecting pathogens. Logic
dictates that this goal can be accomplished by mosquito proofing of dwellings. People
who are immobilized by illness are more likely to be at home or in a hospital than
people who do not feel ill; transmission from homes and hospitals therefore should
tend to involve relatively virulent variants. When such dewllings are mosquito-proof,
however, vectors cannot gain access to the severely ill people who are incapacitated
inside these dewllings. The vectors will instead transmit pathogens from those infected
people who feel healthy enough to get up out of bed and walk outdoors. These pathogens
should tend to be relatively benign. The vector proofing of dwellings therefore should
favor transmission of the benign strains from people in the outside environment instead
of transmission of the more virulent strains that infect the bed-ridden. This favoring
of benign strains through the mosquito proofing of dewllings would be manifested as
an evolutionary decline in virulence.
Though this idea has not been tested directly, geographic variations in virulence
and the demonstrated effect of vector proofing of houses on disease transmission suggests
that it will work [17]. Strains of malaria are mild where the potential for vector-borne
transmission is low and sporadic [18], [19], and mosquito proofing of houses has had
a strong inhibitory effect on transmission of plasmodia [20].
2.2
Water-borne transmission
As with vector-borne pathogens, evolutionary theory predicts that water-borne pathogens
should evolve to relatively high levels of virulence, because they can be transmitted
from immobilized people. Reliance on the mobility of infected hosts is low for water-borne
pathogens, because the waste-disposal activities of attendants and the movement of
water can contaminate sources of drinking water. The lethality of diarrheal bacteria
is correlated positively with the extent to which they are water borne [21]. Geographic
comparisons also support the idea that the virulence of diarrheal diseases is linked
to water-borne transmission; among Shigella, for example, severe strains have been
disproportionately common where the potential for water-borne transmission is high
[15].
Changes in such ratios over time support the idea that the virulence of diarrheal
pathogens couuld be managed evolutionary by blocking water-borne transmission. Diarrheal
pathogens, such as Shigella and Vibrio cholerae, evolved toward lower virulence as
the water supplies were cleaned up in North America, South America, Europe, and Asia.
[17], [21].
2.3
Attendant-borne transmission in hospitals
Like vector-borne and water-borne pathogens, pathogens acquired while in the hospital
can be transmitted from immobile hosts. In this case, the transporting is done on
the hands of doctors, nurses, and other attendants and the objects they touch. Such
attendant-borne transmission is the major route for most serious hospital-acquired
pathogens, such as the staphylococci, streptococci, enterococci, Pseudomonas, and
Clostridium difficile
[15]. Attendants usually do not get infected, partly because they are less vulnerable
than their patients, they wash their hands before leaving the environment, and they
may have generated some immunity to the hospital organisms.
Although the evolution of virulence in hospitals has been studied only superficially,
the available information supports the idea that cycling in hospitals makes pathogens
more harmful. A review of all hospital outbreaks of Escherichia coli-related infection
that occurred in the United States and United Kingdom before the effective use of
antibiotics assessed whether increased attendant-borne transmission was associated
with increased lethality [22]. A statistically significant association was found;
strains that had been circulating for a week rarely caused death, but strains that
had circulated for many months killed about 1 in 10 infants [22].
The implications for virulence management of attendant-borne transmission in hospitals
mirror the implications for vector-borne and water-borne pathogens. If the attendant-borne
transmission is blocked through proper hand washing and glove use, strains circulating
in hospitals increasingly are represented by strains that are brought from the outside
community; such community strains depend on host mobility for transmission and tend
to be less virulent than strains that have been cycling in hospital environments.
2.4
Sit-and-wait pathogens
Pathogens that are durable in the external environment also can be transmitted from
very ill people, because such pathogens can reach susceptible individuals by relying
on the mobility of susceptible, rather than infected, people. The high durability
of smallpox, Mycobacterium tuberculosis, and Corynebacterium diphtheriae in the external
environment helps explain why these pathogens have been scourges throughout history.
The agent of plague, Yersinia pestis, can be transmitted as a durable pathogen by
the respiratory route and as a vector-borne pathogen. A re-analysis of plague from
evolutionary and historical perspectives suggests that both routes were important
in the Black Death of the 14th century [5]. Perhaps it was this combination that led
this outbreak of Y pestis to be so unusually destructive.
As is the case with the preceding categories, virulence management of sit-and-wait
pathogens requires selective blocking of transmission from immobile individuals. In
this case, however, the intervention requires selective inhibition of durable pathogens
from the chain of transmission; this goal could be accomplished by requiring frequent
air exchanges and decontamination of surfaces.
3
Virulence antigen vaccines
Vaccination programs generally do not eradicate target pathogens; at the global level,
only the smallpox vaccine has eradicated its target from the human population. When
eradication does not occur, policymakers must consider effects of vaccination not
only on the frequency of infection but also on the virulence of the pathogens that
are left in the wake of the vaccination program. Vaccination programs that cause evolutionary
reductions in the virulence tend to be successful because they leave behind mild variants
that may circulate and protect unvaccinated individuals against virulent variants
that might remain in the population, arise by mutation, or enter from other areas.
The circulating, benign strains may protect unvaccinated individuals and the population
as a whole against the spread of harmful strains.
This process of virulence management can be accomplished by a virulence antigen strategy.
This strategy dictates that vaccines should be based on virulence antigens (ie, antigens
that make mild but transmissible organisms harmful) [15], [23]. The virulence antigen
strategy differs from the traditional approach to vaccine development, which selects
antigens on the basis of the protection conferred to study subjects regardless of
whether the antigens are virulence antigens. By selectively suppressing the virulent
variants, virulence antigen vaccines force the target pathogens to evolve toward benignity.
The virulence-antigen strategy is well illustrated by the diphtheria toxoid vaccine,
which is based on a modified diphtheria toxin. The intact toxin liberates nutrients
to the bacterium by killing nearby human cells. The immunologic response to the toxoid
vaccine neutralizes the toxin and causes the toxin to be a net drain on the bacterium's
nutrient budget. Toxinless C diphtheriae still can infect and be transmitted from
people [24]; the toxin therefore qualifies as a virulence antigen, because it makes
viable benign pathogens harmful. When vaccination prevents the negative effects of
the toxin, the toxinless strains should have a competitive advantage over the toxigenic
strains, because the toxinless strains do not waste valuable resources by producing
an ineffective toxin. Toxinless strains therefore should increase in frequency relative
to toxigenic-strains wherever toxoid vaccines have been administered extensively.
This transition is confirmed by the historical data [25], [26], [27], [28]. The most
detailed data set came from the vaccination program administered in Romania from 1958
through 1972. As the acquired immunity rose to 97%, the percentage of isolates that
produced toxin dropped from 86% to 3%, and diphtheria vanished [27].
If all of the costs of vaccine development and administration could be tallied and
health benefits per dollar spent calculated, the control of diphtheria by the toxoid
vaccine surely would be one of the most cost-effective vaccine programs in history.
Only the smallpox vaccination program would rank higher, because it eradicated smallpox,
which allowed for the abandonment of continuous vaccination.
4
Sexually transmitted diseases: a bridge between acute and chronic infectious diseases
Theory about the evolution of virulence is fundamentally different for chronic infectious
diseases than for acute infectious diseases. This difference is well illustrated by
the virulence of sexually transmitted diseases, which are intermediate between acute
and chronic infectious diseases. Syphilis has an acute phase that is characterized
by a primary chancre, an early chronic phase that is characterized by a pervasive
rash, and a late chronic phase (tertiary syphilis), which may involve mental illness,
tumors, paralysis, meningitis, tremors, and cardiovascular disease. In other sexually
transmitted diseases, the acute phase is inconspicuous or entirely lacking. HIV type
1 (HIV-1) causes a mild flu-like illness within about a month of the onset of infection
but is generally lethal in its chronic phase. The human T-lymphotropic virus type
1 causes asymptomatic acute infection soon after the onset of infection but causes
paralysis, leukemia, or lymphoma decades later in a minority of infected people.
Because infected hosts generally must be mobile to engage in sexual activity, natural
selection favors benignity of sexually transmitted pathogens over the short run. To
be successful in the context of natural selection, however, sexually transmitted parasites
must be infectious over relatively long periods of time, because options for sexual
transmission of a given infection are generally less frequent than opportunities for
transmission of typical agents of acute infectious diseases—a person generally has
sex with many fewer people per week than he can sneeze on. Natural selection therefore
favors long-term persistence and contagiousness of sexually transmitted pathogens
within each host. Accordingly, most sexually transmitted pathogens are characterized
by adaptations that allow the pathogen to evade the immune system to persist in and
be transmitted from the body. Although sexually transmitted pathogens are molded by
natural selection to be benign over the short run, this long-term persistence within
hosts raises the possibility of long-term damage, even though there is low probability
of severe damage during any small period of time during the first years of infection.
According to this framework, the evolution of virulence depends on the potential for
sexual transmission in the host population. If the population is characterized by
a high potential for sexual transmission (high rates of partner changes and unprotected
intercourse), pathogen variants that replicate to relatively high levels soon after
infection tend to have a greater chance of being transmitted to new partners. If the
host population is characterized by a low potential for sexual transmission, the chance
of a partner change occurring soon after infection is low, and the advantages of a
high shedding of pathogens soon after infection is also low. If sexual partners remain
together for a long period of time, a low probability of infecting the partner per
act of sexual intercourse is of little consequence to the probability of pathogen
transmission between the partners, because a large number of sexual contacts will
occur during the long-term relationship. The low potential for sexual transmission
thus favors low levels of exploitation and low virulence. A high potential for sexual
transmission should favor elevated exploitation, which should increase the chances
that negative side effects eventually will occur in the long run.
This theoretical framework leads to two central predictions: The virulence of sexually
transmitted pathogens (1) should be greater in populations in which the potential
for sexual transmission is greater and (2) should increase within a population in
response to an increase in the potential for sexual transmission. Tests of these predictions
uniformly have confirmed them whenever comparisons provide clear differences in the
potential for sexual transmission and the virulence of infections. These comparisons
involve HIV, human papillomavirus, human herpesvirus 2, and human T-lymphotropic viruses
[29].
The confirmations suggest that the virulence of sexually transmitted pathogens could
be reduced by reducing the potential for sexual transmission through interventions
designed to reduce partner changes and increase the use of barrier-type contraception.
Information on the virulence of sexually transmitted pathogens from restricted regions
provides a sense of the potential effect of such interventions.
The evidence from Senegal is perhaps the most informative in this regard. The population
in Senegal has a low potential for sexual transmission relative to populations of
other countries in sub-Saharan Africa. The relatively benign HIV type 2 has not been
replaced by the more virulent HIV-1 in Senegal, as it has in other areas of West Africa
[30]. The HIV-1 subtype that predominates in Senegal is more benign than the HIV-1
subtypes that predominate in sub-Saharan countries with a higher potential for sexual
transmission [31]. A similar difference occurs among the strains of the sexually transmitted
bacterium Chlamydia trachomatis. The strains of C trachomatis that predominate in
Senegal are more mild than the strains that predominate in sub-Saharan countries with
a higher potential for sexual transmission [32]. These comparisons illustrate how
a low potential for sexual transmission can favor benign sexually transmitted pathogens
even in relatively small populations that are not isolated from surrounding populations.
5
Infectious causes of chronic diseases
Chronic infectious diseases may seem passé relative to the acute emerging diseases
that have monopolized the headlines, such as Ebola virus and severe acute respiratory
syndrome. Chronic diseases, however, pose a much greater threat over the near term,
and something important probably can be done to control them if their causes are examined.
These two claims may seem presumptuous at first. The worst plagues of history have
been acute infectious diseases that spread swiftly and lethally through human populations.
The most damaging examples generally have been well adapted to transmission through
human populations, either directly from person to person or indirectly through a biologic
vector, such as a mosquito, or a nonbiologic vehicle, such as water. These diseases
as a rule were long-adapted to humans and caused their harm when they spread through
previously unexposed human populations. Measles and smallpox decimated native populations
in the Americas when they were introduced during the early colonial period [1], [2],
[3], [4]. Syphilis probably caused large amounts of death in previously unexposed
populations in Europe as a result of a reciprocal introduction into Europe from the
New World [33], [34]. These outbreaks were devastating largely because they were introduced
from human populations with which they had been in evolutionary arms races into populations
that had no acquired immunity and little if any evolved resistance. Terrible new outbreaks
of long-standing human diseases are unlikely to be a great threat in the future because
the current high level of worldwide transportation is far greater than the level needed
for global transport of well-adapted human pathogens. So far as is known, the only
pathogens of humans that have not already been mixed globally by human travel are
zoonotic (ie, newly introduced into humans from other species). Zoonotic diseases
generally have limited potential for spread in human populations and therefore have
little potential for causing devastating epidemics. AIDS is the only exception; however,
even AIDS causes minor damage compared with the decimation that was caused in New
World populations on contact with Old World pathogens.
The diseases that are known to be a threat in the near future are those that currently
are killing massive numbers of humans. In rich countries, these diseases are chronic
diseases that have been and still widely are presumed to be caused by bad genes and
harmful environments rather than by infectious agents. For most of the 20th century,
the accepted wisdom has been that the scope of infectious chronic diseases is narrow,
largely limited to the chronic phases of sexually transmitted diseases and a handful
of other diseases, such as tuberculosis and shingles, diseases that were thought of
as chronic sequelae to acute infectious diseases.
Evolutionary theory, however, suggests that many if not most of the major chronic
diseases of humans are caused by infection [35]. The logic leading to this conclusion
involves a simple application of natural selection. There are three general categories
of disease causation: genetic, parasitic, and nonparasitic environmental. (“Parasitic”
is broadly defined to include infectious causes.) Evolutionary considerations severely
limit the feasibility of genetic causation for the most common severe chronic diseases,
because such diseases tend to reduce any causal alleles down to a frequency that can
be maintained by mutation [35]. If an allele provides some compensating benefit (as
is the case with the allele for sickle cell anemia), it can be maintained, but few
of the common and harmful diseases with unknown causes have characteristics that are
consistent with such a scenario. Although a great amount of research effort has been
spent on attempts to discover genetic causes of chronic diseases, this research generally
has identified only genetic predispositions to common damaging diseases rather than
direct causes. Even in the case of cancer, where mutational causes have been identified,
these causes are insufficient to explain any more than a minuscule portion of human
cancer without invoking other categories of causation. In no case has the research
on genetic causation of chronic disease led to a practical breakthrough that decisively
controls or cures any common and damaging chronic disease. In contrast to this lack
of success, infectious causes of chronic diseases have been documented (Table 1
), and preventive or curative interventions have been enacted (with vastly less funding).
Peptic ulcers, stomach cancer, and liver cancer are recognized as being caused by
infection. Peptic ulcers and some stomach cancer can be cured and prevented by antibiotic
treatment [36], and many cases of liver cancer have been prevented by screening the
blood supply for hepatitis B and C viruses. Infectious agents have been associated
with a large proportion of the most common severe chronic diseases of unknown cause,
such as diabetes, Alzheimer's disease, atherosclerosis, and schizophrenia (Table 2
). Because infectious causation of chronic diseases generally cannot be demonstrated
with the same level of certainty as infectious causation of acute diseases (eg, Koch's
postulates generally cannot be satisfied), acceptance of infectious causation is more
protracted for chronic diseases [35]. The evidence for infectious causation of these
diseases is steadily mounting and often is making sense of the evidence for genetic
and noninfectious environmental causation.
Table 1
Chronic diseases with an infectious cause (virus, bacteria or protozoan) accepted
over the past quarter century
Disease
Infectious cause
Sexual transmissiona
Tropical spastic paraparesis
Human T-lymphotropic virus type 1
Yes, genitally
AIDS
HIV
Yes, genitally
Reactive arthritis
C trachomatis
Yes, genitally
Cervical cancer
Human papillomavirus serotypes
Yes, genitally
Ramsay Hunt syndrome
Varicella zoster virus
No, respiratory
Progressive multifocal leukoencephalopathy
JC virus
No?
Subacute sclerosing panencephalitis
Measles virus
No, respiratory
Kaposi's sarcoma
Human herpes virus 8
Yes [38]
Liver cancer
Hepatitis B virus
Yes, sexual
Liver cancer
Hepatitis C virus
Yes?, sexual? [39], [40]
Stomach cancer
Helicobacter pylori
No
Gingivitis
Porphyromonas gingivalis
Yes, orally
Peptic ulcers
H pylori
No
Infertility
C trachomatis
Yes
Ectopic pregnancy
C trachomatis
Yes
Rheumatoid arthritis
Streptococcus pyogenes
Mostly no (some orally)
A question mark indicates transmission route is uncertain.
a
Most sexually transmitted pathogens can be transmitted by other routes. A “yes” in
this column indicates that sexual transmission is considered to be an important, but
not necessarily only, mode of transmission.
Table 2
Chronic diseases with suspected infectious causes
Disease
Suspected pathogens
Reference
Amyotrophic lateral sclerosis
Echovirus (n)
[41], [42]
Alzheimer's disease (sporadic)
C Pneumoniae (n), human herpes simplex type 1 (s-o)
[43], [44]
Multiple sclerosis
C Pneumoniae (n), EBV (s-o)
[45], [46], [47]
Schizophrenia
Toxoplasma gondii (n?), human herpes simplex type 2 (s), bornavirus (n?)
[48], [49], [50], [51], [52], [53], [54]
Bipolar disorder
Bornavirus (n?)
[55]
Juvenile onset obsessive compulsive disorder
Streptococcus pyogenes (n, but some s-o)
[56]
Systemic lupus erythematosus
EBV (s-o), T. gondi (n?)
[57], [58]
Atherosclerosis and stroke
C pneumoniae (n), cytomegalovirus (s-o,s-g), Porphyromonas gingivalis (s-o)
[59], [60], [61], [62], [63]
Childhood leukemia
EBV (s-o)
[64]
Head and neck cancers
Human papiloma virus (s-g)
[65]
Breast cancer
Mouse mammary tumor-like virus (n?), EBV (s-o)
[66], [67]
Colon cancer
JC virus (n?)
[68], [69]
Type 2 diabetes
Hepatitis C virus (s?)
[70]
Crohn's disease
Mycobacterium paratuberculosis (n)
[71]
A question mark indicates transmission route is uncertain.
Abbreviations: EBV, Epstein-Barr virus; n, nonsexually transmitted; s-o, sexually
transmitted by oral contact; s-g, sexually transmitted by genital contact.
This coalescence of perspectives is well illustrated by the ε4 allele-associated diseases:
atherosclerosis, stroke, Alzheimer's disease, rheumatoid arthritis, and multiple sclerosis.
The ε4 allele is maintained at frequencies that range from about 5% to 50% in different
human populations. Its frequency is lowest in populations that have been living in
high densities for the past few thousand years. The frequency is higher in populations
that have been relatively small and isolated during this time, and it is highest in
people who have been hunter–gatherers into the 20th century. Even the lowest frequency
of the ε4 allele is too great to be maintained simply by mutation. The ε4 allele is
the primary allelic form of the apolipoprotein E gene in other primates and cannot
be considered a defective allele. One possible explanation is that the ε4 allele increases
vulnerability to at least one infectious cause of the ε4 allele-associated diseases.
Although many pathogens have been associated with these diseases (Table 2), one pathogen,
Chlamydia pneumoniae, has been associated with all of them. This finding raises the
possibility that the ε4 allele increases vulnerability to C pneumoniae infection.
As a respiratory-tract pathogen, C pneumoniae undoubtedly inflicts a heavier cost
on dense human populations than on sparse populations. If so, the longer that a particular
ethnic group has lived in high-density populations, the greater the cumulative selective
pressure against the ε4 allele. In accordance with this scenario, individuals who
are infected with C pneumoniae are about four times as likely to have the ε4 allele
as are individuals from the general population [37]. C pneumoniae apparently has evolved
to take advantage of people who have the ε4 allele and has driven down the frequency
of ε4 allele over time.
The theoretical framework for understanding the evolution of virulence of sexually
transmitted pathogens provides clues about which infectious agents are the most likely
causes of these illnesses. The primary requirement for infectious causation of chronic
disease is persistent infection, and this theoretical framework proposes that sexual
transmission favors persistent infections more than any other mode of transmission.
One caveat applies. Pathogens transmitted by sexual oral contact should be selected
to be persistent for the same reason that pathogens transmitted by sexual genital
contact are selected to be persistent (ie, because sexual oral contact occurs rarely
relative to contact through coughing or sneezing). If sexual transmission is defined
broadly to include transmission through sexual oral and genital contact, sexually
transmitted pathogens over the past quarter century have been responsible for a disproportionately
large fraction of the chronic diseases that have been accepted as being caused by
infection; about 20% of all human pathogens are sexually transmitted by this definition,
but about half of the pathogens that cause these chronic diseases are sexually transmitted
(see Table 1). They are also candidate causes of the chronic diseases for which infectious
causation strongly is implicated but not yet accepted (see Table 2). To identify infectious
causes of chronic diseases, one should look closely at the sexually transmitted pathogens.